Skip to main content
    E

    Entero Therapeutics, Inc. (ENTO)

    Official site

    BIOTECHNOLOGY

    $3.30
    -0.44 (-11.76%)

    Last updated: Nov 16, 2026 at 4:00 PM ET

    Entero Therapeutics, Inc. (ENTO) Stock Chart

    Updated Nov 16, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Entero Therapeutics (ENTO) closed at $3.30 on Nov 16, 2026. Its price fell 10.1% over the past 12 months. The month-end price fell 100.0% over the 10 years through Oct 2026, a compound annual decline of 69.2%.

    Price Chart

    From Oct 2016 to Oct 2026, its highest month-end close was $639,331.61 in Oct 2016 and its lowest $1.02 in Apr 2025, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart ENTO with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for ENTO.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 15.2%, and over 6 months it fell 12.7%. The month-end price fell 71.4% over the 3 years through Oct 2026, a compound annual decline of 34.1%.

    PeriodChange
    1 month-21.8%
    3 months-15.2%
    6 months-12.7%
    12 months-10.1%
    12 months, with dividends-10.1%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years-71.4%-34.1%
    5 years-100.0%-82.7%
    10 years-100.0%-69.2%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2025, when the price rose 149.7%, and its weakest was 2022, when it fell 98.0%.

    YearCloseChange
    2026 through Oct 2026$4.96+6.4%
    2025$4.66+149.7%
    2024$1.87-85.2%
    2023$12.60-96.6%
    2022$367.68-98.0%
    2021$18,221.58-85.1%
    2020$122,317.88-6.7%
    2019$131,144.95-14.0%
    2018$152,582.10-66.7%
    2017$458,629.01-23.3%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 22.7% below its 50-day average of $4.27 and 8.4% below its 200-day average of $3.60.

    MeasureValuePrice vs
    Close (Nov 16, 2026)$3.30
    50-day average$4.27-22.7%
    200-day average$3.60-8.4%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 97.4%.

    MeasureValue
    1-year beta2.62
    Largest fall, 1 year-61.8%
    Largest fall, 3 years-97.4%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About ENTO

    What is ENTO's 1-year price change?

    Entero Therapeutics's price fell 10.1% over the past 12 months. With dividends included, the 12-month total return was -10.1%.

    What is ENTO's 5-year price change?

    Entero Therapeutics's month-end price fell 100.0% over the 5 years through Oct 2026, a compound annual decline of 82.7%. These figures leave out dividends.

    What is ENTO's beta?

    Entero Therapeutics's 1-year beta against the S&P 500 is 2.62, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 61.8%.

    Is the ENTO chart free?

    Yes. Advanced Charting for ENTO is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.